Bristol-Myers Squibb Company
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.
POSTED
09-27-22
From Patient to Physician: Trading Places
"Why am I so passionate about making patients a No. 1 priority? In part, it’s because at an early age I had an experience as a patient myself that made a big impression on me."
POSTED
09-21-22
Keep the Wheels Turning
At Bristol Myers Squibb, Global Patient Week stands as a pinnacle of our year-round vision to transform patients’ lives through science, bringing together our more than 32,000 employees around the world to celebrate the individuals we work each day to serve.
POSTED
09-15-22
Exploring Pathways in Immune-Mediated Diseases To Advance Patient Care
The idea of using one drug to treat many diseases is not entirely new. Historically, therapeutics like immunosuppressants or steroids have been used broadly across many immune-mediated diseases.
POSTED
09-13-22
Using the Power of Technology To Better Serve Our Patients
It's inevitable: Thanks to technology, we are going to see true breakthroughs in finding powerful medicines, and in treating, diagnosing and, hopefully, curing diseases.
POSTED
09-08-22
Bristol Myers Squibb Employees to Relay Nearly 3,000 Miles Cross-Country Aspiring to Raise Over $1 Million for the V Foundation for Cancer Research
Bristol Myers Squibb employees will embark on a cross-country bike ride from the coast of Oregon to honor loved ones who have been impacted by cancer by raising money to support the V Foundation for Cancer Research.
POSTED
08-24-22
From Numbers to Knowledge: Unlocking the Predictive Power of Data To Accelerate Transformative Science
Scientists and experts at Bristol Myers Squibb are working to revolutionize the process of drug development with sophisticated scientific strategies driven by technology.
POSTED
08-02-22
C2C4C: Back on the Road and Bigger Than Ever
Nearly a decade ago, the first Coast 2 Coast 4 Cancer cycling event began with 53 employees riding 3,000 miles across the U.S. to honor loved ones impacted by cancer by raising funds for cancer research.
POSTED
07-22-22
The Future of Diversity in Clinical Trials
As part of the Bristol Myers Squibb Foundation’s $100+ million initiative to increase diversity in clinical trials, Winn CIPP is a six-week immersive summer service-learning experience that aims to train more than 250 diverse clinical investigators.
POSTED
07-13-22
Pioneering Paths Forward in Immunology
At Bristol Myers Squibb, we are building a portfolio grounded in pathbreaking science that addresses unmet needs for people living with immune-mediated diseases in rheumatology, gastroenterology, dermatology and neurology.
POSTED
06-23-22
Juneteenth: Remembering the Past, Reimagining the Future
On June 20, Bristol Myers Squibb has reserved the day to honor Juneteenth, to allow the workforce to pause, reflect and play a part in a culture of inclusion.